Update on vancomycin resistance

International Journal of Clinical Practice

Volumn 54, Issue 4, 2000, Pages 250-254

  Perichon, B ^a   Courvalin, Patrice ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDE; PEPTIDOGLYCAN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; ENTEROCOCCUS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANTI-BACTERIAL AGENTS; ENTEROCOCCUS; HUMANS; STREPTOCOCCAL INFECTIONS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0034110689     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Reynolds PE. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 1989; 8: 943-950.
2. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157-161.
3. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988; i: 57-58.
4. Arthur M, Reynolds PE, Courvalin P. Glycopeptide resistance in enterococci. Trends Microbiol 1996; 4: 401-407.
5. Perichon B, Reynolds P, Courvalin P. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother 1997; 41: 2016-2018.
6. Fines M, Perichon B, Reynolds PE et al. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother 1999; 43: 2161-2164.
7. Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacterial 1993; 175: 117-127.
8. Leclercq R, Dutka-Malen S, Duval J, Courvalin P. Vancomycin resistance gene vanC is specific to Enterococcus gallinarum. Antimicrob Agents Chemother 1992; 36: 2005-2008.
9. Navarro F, Courvalin P. Analysis of genes encoding D-alanine:D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob Agents Chemother 1994; 38: 1788-1793.
10. Brisson-Noël A, Dutka-Malen S, Molinas C et al. Cloning and heterospecific expression of the resistance determinant vanA encoding high-level resistance to glycopeptides in Enterococcus faecium BM4147. Antimicrob Agents Chemother 1990; 34: 924-927.
11. Dutka-Malen S, Molinas C, Arthur M, Courvalin P. The VANA glycopeptide resistance protein is related to D-alanyl:D-alanine ligase cell wall biosynthesis enzymes. Mol Gen Genet 1990; 224: 364-372.
12. Arthur M, Molinas C, Bugg TDH et al. Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci. Antimicrob Agents Chemother 1992; 36: 867-869.
13. Bugg TDH, Wright GD, Dutka-Malen S et al. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and Van A. Biochemistry 1991; 30: 10408-10415.
14. Reynolds PE, Depardieu F, Dutka-Malen S et al. Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine. Mol Microbiol 1994; 13: 1065-1070.
15. Arthur M, Depardieu F, Molinas C et al. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene 1995; 154: 87-92.
16. Arthur M, Molinas C, Courvalin P. The VanR-VanS two-component regulatory system controls synthesis of depsipeptide peplidoglycan precursors in Enterococcus faecium BM4147. J Bacterial 1992; 174: 2582-2591.
17. Quintiliani JR Jr, Evers S, Courvalin P. The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci. J Infect Dis 1993; 167: 1220-1223.
18. Quintiliani JR Jr, Courvalin P. Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves the movement of large genetic elements from chromosome to chromosome. FEMS Microbiol Lett 1994; 119: 359-364.
19. Quintiliani JR Jr, Courvalin P. Characterization of Tn1547, a composite transposon flanked by the IS16 and IS256-like elements, that confers vancomycin resistance in Enterococcus faecalis BM4281. Gene 1996; 172: 1-8.
20. Woodford N, Jones BL, Baccus Z et al. Linkage of vancomycin and high-level gentamicin resistance on the same plasmid in a clinical isolate of Enterococcus faecalis. J Antimicrob Chemother 1995; 35: 179-184.
21. Casadewall B, Courvalin P. Characterization of the vanD glycopeptide resistance gene cluster from Enterococcus faecium BM4339. J Bacteriol 1999; 181: 3644-3648.
22. Perichon B, Casadewall B, Reynolds PE, Courvalin P. Glycopeptide-resistant Enterococcus faecium BM4416 is a VanD-type strain with an impaired D-alanine:D-alanine ligase. Antimicrob Agents Chemother 2000. In press.
23. Clark NC, Teixeira LM, Facklam RR, FC Tenover FC. Detection and differentiation of vanC-1, vanC-2, and vanC-3 glycopeptide resistance genes in enterococci. J Clin Microbiol 1998; 36: 2294-2297.
24. Arias CA, Martin-Martinez M, TL Blundell et al. Characterization and modelling of VanT: a novel, membrane-bound, serine racemase from vancomycin-resistant Enterococcus gallinarum BM4174. Mol Microbiol 1999; 31: 1653-1664.
25. c encodes D,D-dipeptidase (VanX) and D,D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174. Mol Microbiol 1999; 34: 341-349.
26. Reynolds PE, Snaith HA, Maguire AJ et al. Analysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum BM4174. Biochem J 1994; 301: 5-8.
27. Evers S, Casadewall B, Charles M et al. Evolution of structure and substrate specificity in D-alanine:D-alanine ligases and related enzymes. J Mol Evol 1996; 42: 706-712.
28. Marshall CG, Broadhead G, Leskiw BK, Wright GD. D-Ala-D-Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB. Proc Natl Acad Sci USA 1997; 94: 6480-6483.
29. Marshall CG, Lessard AD, Park IS, Wright GD. Glycopeplide antibiotic resistance genes in glycopeptide-producing organisms. Antimicrob Agents Chemother 1998; 42: 2215-2220.
30. Dever LL, Smith SM, Handwerger S, Eng RHK. Vancomycin-dependent Enterococcus faecium isolated from stool following oral vancomycin therapy. J Clin Microbiol 1995; 33: 2770-2773.
31. Farrag N, Eltringham I, Liddy H. Vancomycin-dependent Enterococcus faecalis. Lancet 1996; 348: 1581-1582.
32. Fraimow HS, Jundkind DL, Lander DW et al. Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth. Ann Intern Med 1994; 121: 22-26.
33. Green M, Shlaes JH, Barbadora K, Shlaes DM. Bacteremia due to vancomycin-dependent Enterococcus faecium. Clin Infect Dis 1995; 20: 712-714.
34. Van Bambeke F, Chauvel M, Reynolds PE et al. Vancomycin-dependent Enterococcus faecalis clinical isolates and revenant mutants. Antimicrob Agents Chemother 1999; 43: 41-47.
35. Baptista M, Depardieu F, Reynolds PE et al. Mutations leading to increased levels of resistance to glycopeptide antibiotics in Van-B-type enterococci. Mol Microbiol 1997; 25: 93-105.